US subsidiary

US subsidiary
Colin Kerr
Colin Kerr
Published: Wednesday, November 1, 2017
Rayner has established a dedicated subsidiary for the US market, ‘Rayner Surgical Inc’. “Based out of New York, Rayner Surgical Inc will provide US-specific marketing, regulatory, commercial and research functions to Rayner. From its offices at 100 Park Avenue, NYC, Rayner Surgical Inc will actively promote and support the growth and development of Rayner’s business in the US,” said a Rayner spokeswoman. “A new, physical US presence will strengthen Rayner’s relationships with US surgeons, universities and key opinion leaders (KOLs), generating valuable collaborative partnerships and identifying new opportunities in IOL design and innovation,” she said. www.rayner.com
Tags: rayner
Latest Articles
Organising for Success

Professional and personal goals drive practice ownership and operational choices.

Read more...

Update on Astigmatism Analysis

Read more...

Is Frugal Innovation Possible in Ophthalmology?

Improving access through financially and environmentally sustainable innovation.

Read more...

iNovation Innovators Den Boosts Eye Care Pioneers

New ideas and industry, colleague, and funding contacts among the benefits.

Read more...

From Concept to Clinic

Partnerships with academia and industry promote innovation.

Read more...

José Güell: Trends in Cornea Treatment

Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.

Read more...

Making IOLs a More Personal Choice

Surgeons may prefer some IOLs for their patients, but what about for themselves?

Read more...

Need to Know: Higher-Order Aberrations and Polynomials

This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.

Read more...

Never Go In Blind

Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.

Read more...

Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...